CS175500B2 - - Google Patents
Info
- Publication number
- CS175500B2 CS175500B2 CS215A CS21576A CS175500B2 CS 175500 B2 CS175500 B2 CS 175500B2 CS 215 A CS215 A CS 215A CS 21576 A CS21576 A CS 21576A CS 175500 B2 CS175500 B2 CS 175500B2
- Authority
- CS
- Czechoslovakia
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2438020A DE2438020A1 (de) | 1974-08-05 | 1974-08-05 | 18-methyl-19-nor-20-keto-pregnane und verfahren zu ihrer herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
CS175500B2 true CS175500B2 (cs) | 1977-05-31 |
Family
ID=5922668
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS215A CS175500B2 (cs) | 1974-08-05 | 1975-07-22 | |
CS5170A CS175498B2 (cs) | 1974-08-05 | 1975-07-22 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS5170A CS175498B2 (cs) | 1974-08-05 | 1975-07-22 |
Country Status (17)
Country | Link |
---|---|
US (1) | US4029777A (cs) |
JP (1) | JPS5141347A (cs) |
AT (1) | AT345998B (cs) |
BE (1) | BE832124A (cs) |
CA (1) | CA1037027A (cs) |
CH (1) | CH611910A5 (cs) |
CS (2) | CS175500B2 (cs) |
DD (1) | DD120192A5 (cs) |
DE (1) | DE2438020A1 (cs) |
DK (1) | DK136369C (cs) |
ES (1) | ES439720A1 (cs) |
FR (1) | FR2281123A1 (cs) |
GB (1) | GB1512258A (cs) |
HU (1) | HU171684B (cs) |
IL (1) | IL47770A (cs) |
NL (1) | NL7509326A (cs) |
SE (1) | SE404804B (cs) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61144199A (ja) * | 1984-12-18 | 1986-07-01 | Pioneer Electronic Corp | スピ−カ用紙製振動部材の製造方法 |
US5232917A (en) * | 1987-08-25 | 1993-08-03 | University Of Southern California | Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
AU609927B2 (en) * | 1987-08-25 | 1991-05-09 | Kelvin W. Gee | Compositions and methods for alleviating stress, anxiety and seizure activity |
US5175154A (en) * | 1987-11-25 | 1992-12-29 | Research Corporation Technologies, Inc. | 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds |
WO2014169836A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor neuroactive steroids and methods of use thereof |
RU2700264C2 (ru) | 2013-04-17 | 2019-09-16 | Сейдж Терапьютикс, Инк. | 19-нор нейроактивные стероиды и способы их применения |
KR102239541B1 (ko) | 2013-04-17 | 2021-04-14 | 세이지 테라퓨틱스, 인크. | 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법 |
WO2014169831A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof |
EP3868382A1 (en) | 2013-07-19 | 2021-08-25 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
LT3488852T (lt) | 2013-08-23 | 2021-02-25 | Sage Therapeutics, Inc. | Neuroaktyvūs steroidai, kompozicijos, ir jų naudojimas |
US10246482B2 (en) | 2014-06-18 | 2019-04-02 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
BR112017007902B1 (pt) | 2014-10-16 | 2023-12-05 | Sage Therapeutics, Inc | Composto e seu sal, composição farmacêutica e uso do referido composto e seu sal na fabricação de um medicamento para o tratamento de distúrbios do sistema nervoso central |
LT3206493T (lt) | 2014-10-16 | 2020-08-25 | Sage Therapeutics, Inc. | Kompozicijos ir būdai, skirti cns sutrikimams gydyti |
SI3224269T1 (sl) | 2014-11-27 | 2020-10-30 | Sage Therapeutics, Inc. | Sestavki in metode za zdravljenje CNS motenj |
ES2857082T3 (es) | 2015-01-26 | 2021-09-28 | Sage Therapeutics Inc | Composiciones y métodos para el tratamiento de trastornos del SNC |
JP6875996B2 (ja) | 2015-02-20 | 2021-05-26 | セージ セラピューティクス, インコーポレイテッド | 神経刺激性ステロイド、組成物、およびその使用 |
DK3481844T3 (da) | 2016-07-11 | 2024-07-22 | Sage Therapeutics Inc | C7, C12 og C16 substituerede neuroaktive steroider og disses fremgangsmåder til anvendelse |
MA45599A (fr) | 2016-07-11 | 2019-05-15 | Sage Therapeutics Inc | Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation |
BR112020012712A8 (pt) * | 2017-12-22 | 2022-03-03 | Sage Therapeutics Inc | Composto ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica e usos do referido composto para o tratamento de distúrbios do snc |
WO2020243488A1 (en) | 2019-05-31 | 2020-12-03 | Sage Therapeutics, Inc. | Neuroactive steroids and compositions thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1409239A (en) * | 1971-11-11 | 1975-10-08 | Glaxo Lab Ltd | Process for the preparation of 3alpha-hydroxy-5alpha-steroids |
BE791196A (fr) * | 1971-11-11 | 1973-05-10 | Glaxo Lab Ltd | Nouveaux steroides, leur procede de preparation et leurs applications |
-
1974
- 1974-08-05 DE DE2438020A patent/DE2438020A1/de not_active Withdrawn
-
1975
- 1975-07-22 CS CS215A patent/CS175500B2/cs unknown
- 1975-07-22 CS CS5170A patent/CS175498B2/cs unknown
- 1975-07-23 IL IL47770A patent/IL47770A/xx unknown
- 1975-07-24 ES ES439720A patent/ES439720A1/es not_active Expired
- 1975-07-29 DK DK344475A patent/DK136369C/da active
- 1975-08-01 AT AT600475A patent/AT345998B/de not_active IP Right Cessation
- 1975-08-01 CA CA232,730A patent/CA1037027A/en not_active Expired
- 1975-08-01 DD DD187639A patent/DD120192A5/xx unknown
- 1975-08-04 GB GB32477/75A patent/GB1512258A/en not_active Expired
- 1975-08-04 FR FR7524225A patent/FR2281123A1/fr not_active Withdrawn
- 1975-08-04 SE SE7508777A patent/SE404804B/xx unknown
- 1975-08-04 HU HU75SCHE529A patent/HU171684B/hu unknown
- 1975-08-05 CH CH1020975A patent/CH611910A5/xx not_active IP Right Cessation
- 1975-08-05 NL NL7509326A patent/NL7509326A/xx not_active Application Discontinuation
- 1975-08-05 US US05/602,098 patent/US4029777A/en not_active Expired - Lifetime
- 1975-08-05 JP JP50095322A patent/JPS5141347A/ja active Pending
- 1975-08-05 BE BE158941A patent/BE832124A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DK136369B (da) | 1977-10-03 |
DK344475A (da) | 1976-02-06 |
JPS5141347A (en) | 1976-04-07 |
SE7508777L (sv) | 1976-02-06 |
SE404804B (sv) | 1978-10-30 |
ATA600475A (de) | 1978-02-15 |
CA1037027A (en) | 1978-08-22 |
DE2438020A1 (de) | 1976-02-26 |
GB1512258A (en) | 1978-05-24 |
CH611910A5 (cs) | 1979-06-29 |
US4029777A (en) | 1977-06-14 |
HU171684B (hu) | 1978-02-28 |
AU8351575A (en) | 1977-02-03 |
ES439720A1 (es) | 1977-03-01 |
NL7509326A (nl) | 1976-02-09 |
DK136369C (da) | 1978-02-27 |
DD120192A5 (cs) | 1976-06-05 |
AT345998B (de) | 1978-10-10 |
FR2281123A1 (fr) | 1976-03-05 |
IL47770A0 (en) | 1975-10-15 |
IL47770A (en) | 1978-10-31 |
BE832124A (fr) | 1976-02-05 |
CS175498B2 (cs) | 1977-05-31 |